Vedea Healthware receives Early Stage Financing from RVO
Vedea Healthware receives Early Stage
The time has come: Vedea no longer exists in name only, but now also has the financial means to start developing its platform. After an intensive preparation process, we submitted our final application with the founders on 6 August. On 31 August, the Netherlands Enterprise Agency (RVO) approved our financing application. With a loan from Early Phase Financing (VFF), start-ups and SMEs investigate whether their idea has a chance of success on the market. The VFF must ensure that the idea moves from the planning phase to the start-up phase.
This means that we can finally get started on realizing the best new treatment method for children with amblyopia. We are very happy about that and secretly a little proud of it.
For us this is a good day and we hope that in the future we can all look back that today was the start of a beautiful journey that will help many children with amblyopia to get rid of their lazy eye in a child-friendly, efficient and cost-effective way.
We are very much looking forward to the coming months and hope to take you/you with us and would like to hear if you want to join and hear more about the Vedea method. Then please register for our newsletter and stay automatically informed of the latest news.